Pharmasco

Pharmasco Ltd is the Ukrainian private company created in 2002. Activity of the company is based on promotion and distribution of medical devices (rapid tests for detection of diseases including the socially significant diseases such as HIV, Hepatitis B, Hepatitis C, drug addiction etc.) of own production and leading world manufacturers: Alere Technologies GmbH, Germany; HemoCue AB, Sweden; CerTest Biotec S.L, Spain; ABON Biopharm (Hangzhou) Co., Ltd, China etc.

Pharmasco was the pioneer which launched in 2003 DOA (drug of abuse), STD’s (sexually transmitted diseases), ovulation tests on the Ukrainian market. Since the product range was expended, it covers gynecological rapid tests- 40% out of all products; infectious, oncology and cardiology rapid tests – 35%; biochemical analysis tests and other products – 25%.

In 2010 the company launched its own production of diagnostic tests for the detection of HIV infection, Hepatitis B, Hepatitis C, syphilis, myocardial infarction, intestinal infections. Consumers of our rapid tests are the governmental organizations (hospitals, laboratories) and nongovernmental organizations (charities, private clinics and laboratories).

The company is actively involved in social projects. For example, during the flu epidemic the company conducts health education on prevention and early detection of flu. Pharmasco has created and supports two educational web-sites, www.narkotik.net.ua is for the prevention of drug addiction and www.oberemennosti.com is for the planning pregnancy and family.

Please note!
Collaboration of companies with shared values is main goal of this project.
We will read your message and redirect it to a company's employee whom it can be as useful as possible.
Your company has 5 opportunities per year to get acquainted with other companies. If you want to increase this amount, please contact us
Please note, that according to EBA Code of Conduct it is prohibited to perform on the EBA platform any coordinated actions, which may limit the competition between the EBA Members.
Write us in case of additional questions and suggestions.

Spelling error report

The following text will be sent to our editors: